Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S. - West Coast)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Medicilon is a professional pharmaceutical preclinical integrated R&D service contract research organization (CRO), providing a full range of one-stop new drug R&D services, in compliance with Chinese and international filing standards, to pharmaceutical companies and research institutions around the world. Our services cover the entire process of preclinical new drug research, including drug discovery, pharmacology research and preclinical research. Our drug discovery services include chemical synthesis, compound activity screening and optimization, structural biology research, protein target validation, etc.; Pharmacological researches include process research of API and formulation, quality standards and stability research, etc.; Preclinical researches include pharmacodynamics, pharmacokinetics, toxicological safety evaluation, etc.
We focus on the needs of innovation and development of global pharmaceutical industry, based on the key aspects of R&D of innovative drug, and build a comprehensive technology platform covering drug discovery, pharmacological research and preclinical research key technologies with our rich experience in serving the Chinese and international biopharmaceutical industry.
Address: Building No. 5, Lane 67, Libing Road, Zhangjiang High-Tech Park
Tel: +86 (21) 5132-0237
Fax: +86 (21) 5132-0222
Postcode: 201203
Address: No. 585 Chuanda Road, Pudong New Area, Shanghai
Tel: +86 (21) 5859-1500
Fax: +86 (21) 5859-6369
Postcode: 201299
Address: Medicilon Industrial Park, No. 2300 Xuanhuang Road, Pudong New Area, Shanghai
Tel: +86 (21) 6898-5800
Postcode: 201300
Medicilon is a pharmaceutical R&D and contract research organization (CRO) based in Shanghai. We have created a comprehensive technical service platform that integrates compound synthesis, compound activity screening, structural biology, pharmacodynamics evaluation, pharmacokinetics evaluation, toxicology evaluation, preparation research, and new drug filing. We operate in compliance with international standards and are recognized by international drug administrations.In February 2008, Medicilon established Medicilon Preclinical Research (Shanghai) LLC, a subsidiary with a focus on preclinical pharmacokinetics and safety evaluation research.MPI’s animal experiment facilities have been accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), and has obtained NMPA GLP and FDA GLP certification.Our integrated services help clients achieve their R&D goals with efficiency and professionalism while spending less time and cost.